Companies

Candel Therapeutics, Inc. (CADL) SEC filings

CIK 0001841387 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)125000125000
Net income (USD)-38.2 M-37.9 M-18.8 M
Diluted EPS (USD/shares)-0.72-1.31-0.65

Latest filings

FiledFormDescriptionPeriod
2026-10-02442026-09-30
2026-10-02442026-09-30
2026-10-02442026-09-30
2026-09-11442026-09-10
2026-09-10144144
2026-09-10442026-09-08
2026-09-10332026-09-08
2026-09-108-K8-K items 5.02,7.01,9.012026-09-06
2026-09-098-K8-K items 7.01,9.012026-09-09
2026-08-19442026-08-17
2026-08-17144144
2026-08-1310-Q10-Q2026-06-30
2026-08-138-K8-K items 2.02,9.012026-08-13
2026-07-27SCHEDULE 13GSCHEDULE 13G
2026-07-08442026-07-06
2026-07-08332026-07-06
2026-07-01442026-06-29
2026-07-01442026-06-29
2026-07-01442026-06-30
2026-07-01442026-06-30
2026-07-01442026-06-30
2026-06-29144144
2026-06-29144144
2026-06-24442026-06-23
2026-06-24442026-06-23

Forms on file (last 1,000): 4 169, 8-K 85, 144 36, 3 25, 10-Q 16, CORRESP 9, 424B5 7, SCHEDULE 13G 6. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=CADL (0.002 USD), /gw/filings/filings?ticker=CADL&form=8-K, /gw/filings/facts?ticker=CADL&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange